LETTER
Regioselective Hydrogenation of Substituted Quinolines
2829
be isolated in its pure form by simple filtration and eva-
poration of the solvent (bp 59 °C). Surprisingly, in HFIP,
irrespective of the substrate, the reaction seemed to begin
slowly but after around 24 hours the entire product was to-
tally reduced, whereas in MeOH even extended reaction
times did not lead to complete conversion of the tetrahy-
dro- into the decahydro derivative. Products substituted
on the benzene ring were easily reduced following this
pattern (entries 1 and 2). In MeOH (entry 3) after one hour
6-bromoquinoline was fully reduced into its tetrahydro-
derivative accompanied with only 18% of the dehaloge-
nated product. Longer reaction times led only to dehalo-
genated products. In HFIP, after 1 hour, a complex
mixture of type a and b products plus their dehalogenated
analogs were obtained. Products substituted on the pyri-
dine ring at the C-2 were more difficult to reduce and re-
quired longer reaction times. Steric effects do not appear
to play a role as the carboxylic acid derivative 5 (entry 5)
was more easily hydrogenated than the methyl one 4 (en-
try 4). As for the 4-methylquinoline (6), it is noteworthy
that the 5,6,7,8-tetrahydroderivative was selectively ob-
tained in HFIP after 18 hours and required very long reac-
tion time (>48 h) to be converted into the decahydro
derivative. This product is known to be difficult to re-
duce.18 Moreover, it was the first time we obtained such
an isomer. This reactivity is notable as, usually, the same
acidic conditions are required to obtain either 5,6,7,8-tet-
rahydro or decahydro derivatives. Thus, we had expected
to obtain mixtures of both the 5,6,7,8-tetrahydroquino-
lines and the decahydro compounds in HFIP and not the
1,2,3,4-isomers. Thus, we assume that the acidic proper-
ties of HFIP are not the main explanation for the selectiv-
ity measured in this solvent.
References
(1) Katritzky, A. R.; Rachwal, S.; Rachwal, B. Tetrahedron
1996, 52, 15031; and references cited therein.
(2) (a) Wang, W.-B.; Lu, S.-M.; Yang, P.-Y.; Han, X.-W.; Zhou,
Y.-G. J. Am. Chem. Soc. 2003, 125, 10536. (b)Yang, P.-Y.;
Zhou, Y.-G. Tetrahedron: Asymmetry 2004, 15, 1145.
(c) Lu, S.-M.; Han, X.-W.; Zhou, Y.-G. Adv. Synth. Catal.
2004, 346, 909.
(3) Hönel, M.; Vierhapper, F. W. J. Chem. Soc., Perkin Trans. 1
1980, 1933.
(4) (a) Fujita, K.-I.; Kitatsuji, C.; Furukawa, S.; Yamaguchi, R.
Tetrahedron Lett. 2004, 45, 3215. (b) Srikrishna, A.;
Reddy, T. J.; Viswajanani, R. Tetrahedron 1996, 52, 1631.
(5) Wright, G. C.; White, R. E. U.S. Patent 4291163, 1981;
Chem. Abstr. 1981, 96, 19986.
(6) Efange, S. M. N.; Khare, A. B.; Mach, R. H.; Parsons, S. M.
J. Med. Chem. 1999, 42, 2862.
(7) Blaser, H. U.; Jalett, H. P.; Lottenbach, W.; Studer, M. J.
Am. Chem. Soc. 2000, 122, 12675.
(8) Fache, F.; Piva, O. Synlett 2004, 1294.
(9) (a) Campanati, M.; Casagrande, M.; Fagiolino, I.; Lenarda,
M.; Storaro, L.; Battagliarin, M.; Vaccari, A. J. Mol. Catal.
A: Chem. 2002, 184, 267. (b) Campanati, M.; Vaccari, A.;
Piccolo, O. J. Mol. Catal. A: Chem. 2002, 179, 287.
(10) Rh/Al2O3 (5%) was purchased from Acros and used as
received.
(11) All the products have been fully characterized by 1H NMR
(300 MHz) and 13C NMR (75 MHz) and analyses are in
agreement with already published data. Data not fond in the
literature: Product 1b (mixture of diastereoisomers): 1H
NMR (300 MHz, CDCl3): d = 0.94–1.90 (m, 11 H), 2.18 (t,
J = 10.3 Hz) and 2.37 (dd, J = 2.2 Hz, J = 10.7 Hz) for 1H in
the ratio 1:3, 2.69 (m, 2 H), 3.18 (m, 2 H), 3.50 (m)and 3.71
(dt, J = 4.5, J = 11.9 Hz) for 1H in the ratio 1:3. 13C NMR (75
MHz, CDCl3): d = 19.3, 20.4, 23.4, 23.6, 23.7, 24.9, 28.2,
28.9, 30.9, 32.2, 32.4, 34.2 (Ct) and 34.6 (Ct), 45.6 (Cs) and
46.2 (Cs), 60.2 (Ct) and 64.0 (Ct) and 66.9 (Ct), 69.9 (Ct) and
70.4 (Ct) and 70.8 (Ct) and 70.9 (Ct). Product 3a: 1H NMR
(300 MHz, CDCl3): d = 1.83 (t, 2 H, J = 6.0 Hz), 2.63 (t, 2
H, J = 6.0 Hz), 3.19 (t, 2 H, J = 6.0 Hz), 6.34 (d, 1 H, J = 8.1
Hz), 6.97 (m, 2 H). 13C NMR (75 MHz, CDCl3): d = 21.7,
26.9, 42.1, 109.6 (Cq), 116.6, 124.5 (Cq), 129.7, 132.2, 142.7
(Cq).
(12) Pitts, M. R.; Harrison, J. R.; Moody, C. J. J. Chem. Soc.,
Perkin Trans. 1 2001, 955.
(13) Hönel, M.; Vierhapper, F. W. J. Chem. Soc., Perkin Trans. 1
1980, 1933.
(14) Booth, H.; Varghan Griffiths, D.; Jozefowicz, M. L. J.
Chem. Soc., Perkin Trans. 2 1976, 6, 751.
(15) Vierhapper, F. W.; Eliel, E. L. J. Org. Chem. 1975, 40, 2734.
(16) Shuman, R. T.; Ornstein, P. L.; Paschal, J. W.; Gesellden, P.
D. J. Org. Chem. 1990, 55, 738.
Finally, cinchonidine (7), a natural product widely used in
asymmetric synthesis, was fully reduced with this system
in HFIP leading to a mixture of isomers (entry 7).7 In
MeOH no activity was detected, probably for solubility
reasons.
In conclusion, we have shown that it is possible to hydro-
genate selectively substituted quinolines in presence of
Rh/Al2O3 into either 1,2,3,4-tetrahydroderivatives or
decahydroquinolines by a judicious choice of solvent.
Here again, HFIP19 shows interesting properties and
avoids the use of more forcing conditions.20
(17) Swarbrick, M. E.; Lubell, W. D. Chirality 2000, 12, 366.
(18) Uchida, M.; Chihiro, M.; Morita, S.; Kanbe, T.; Yamashita,
H.; Yamasaki, K.; Yabuuchi, Y.; Nakagawa, K. Chem.
Pharm. Bull. 1989, 37, 2109.
Acknowledgment
The author thanks Central Glass Company-Japan, for a generous
gift of HFIP and O. Piva for scientific support.
(19) For a recent review on the use of HFIP in organic synthesis
see: Bégué, J. P.; Bonnet-Delpon, D.; Crousse, B. Synlett
2004, 18.
(20) In a Typical Procedure: Quinoline derivative (1 mmol) and
Rh/Al2O310 (25 mg, 0.01 mmol) were stirred in 1.5 mL of the
selected solvent under 50 bar H2 at r.t. for the requisite time.
The reaction mixture was filtered through celite, the solvent
evaporated and the crude product analyzed by NMR without
further purification.
Synlett 2004, No. 15, 2827–2829 © Thieme Stuttgart · New York